-
February 28: The Week in Cancer News
Researchers find one possible explanation for the link between certain gut bacteria and colorectal cancer, and a study shows that the rate of appendix cancer is rising.
by Kate Yandell
-
On Cancer and Identity
The first time Liza Bernstein was diagnosed with cancer, she wouldn't allow it to be part of her identity. After her third cancer diagnosis, she became an advocate for other patients.
by Liza Bernstein
-
Despite Generic Imatinib, Cost of Treating CML Remains High
The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds.
by Anna Azvolinsky
-
February 21: The Week in Cancer News
A study shows that young cancer survivors have a higher death rate than their siblings in the decades following diagnosis, and a cancer survivor has a baby using immature eggs harvested prior to treatment and matured in the lab.
by Kate Yandell
-
February 14: The Week in Cancer News
A survey finds that outpatient palliative care clinics have become nearly ubiquitous in National Cancer Institute-designated cancer centers, and a group of oncology professionals calls for a cancer patient's bill of rights.
by Kate Yandell
-
Drinking After a Diagnosis
A study illuminates the alcohol consumption habits of cancer survivors.
by Jen Tota McGivney
-
Nothing but Time
A father with metastatic kidney cancer embraces moments with his 3-year-old son while pondering how he'll be remembered.
by Adam P. Stern
-
February 7: The Week in Cancer News
A massive sequencing project reveals that mutations that drive cancer often occur years before the disease is diagnosed, and researchers report preliminary results from a trial for a new form of immunotherapy.
by Kate Yandell
-
Opioid Overdoses in Cancer Patients and Survivors
The number of cancer patients and survivors visiting emergency departments for opioid overdoses more than doubled between 2006 and 2015, but overdoses are still uncommon in this group.
by Emma Yasinski
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona